This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -63.33% and 0.98%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Itamar Medical Ltd. Sponsored ADR (ITMR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of 3.33% and 3.97%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Itamar Medical Ltd. Sponsored ADR (ITMR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Itamar Medical Ltd. Sponsored ADR (ITMR) Moves 6.5% Higher: Will This Strength Last?
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Analysts Estimate Itamar Medical Ltd. Sponsored ADR (ITMR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -7.14% and 0.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for September 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for September 4th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of 10.53% and 12.18%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Itamar Medical Ltd. Sponsored ADR (ITMR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Itamar Medical (ITMR) Soars: Stock Adds 9.7% in Session
by Zacks Equity Research
Itamar Medical (ITMR) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Itamar Medical Ltd. Sponsored ADR (ITMR) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Itamar Medical Ltd. Sponsored ADR (ITMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Itamar Medical's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Itamar Medical.